Visus Therapeutics Announces FDA Acceptance of IND for Presbyopia-Correcting Eye Drop
SEATTLE--(BUSINESS WIRE)--The FDA accepts Visus Therapeutics' Investigational New Drug Application, allowing the initiation of a Phase 2 study of BRIMOCHOL for presbyopia